Your browser doesn't support javascript.
loading
Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates.
Diamond, Joshua M; Anderson, Michaela R; Cantu, Edward; Clausen, Emily S; Shashaty, Michael G S; Kalman, Laurel; Oyster, Michelle; Crespo, Maria M; Bermudez, Christian A; Benvenuto, Luke; Palmer, Scott M; Snyder, Laurie D; Hartwig, Matthew G; Wille, Keith; Hage, Chadi; McDyer, John F; Merlo, Christian A; Shah, Pali D; Orens, Jonathan B; Dhillon, Ghundeep S; Lama, Vibha N; Patel, Mrunal G; Singer, Jonathan P; Hachem, Ramsey R; Michelson, Andrew P; Hsu, Jesse; Russell Localio, A; Christie, Jason D.
Afiliación
  • Diamond JM; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: joshua.diamond@pennmedicine.upenn.edu.
  • Anderson MR; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Cantu E; Division of Cardiovascular Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Clausen ES; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Shashaty MGS; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Kalman L; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Oyster M; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Crespo MM; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Bermudez CA; Division of Cardiovascular Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Benvenuto L; Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University School of Medicine, New York, New York.
  • Palmer SM; Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina.
  • Snyder LD; Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina.
  • Hartwig MG; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
  • Wille K; Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Hage C; Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • McDyer JF; Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Merlo CA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University Medical Center, Baltimore, Maryland.
  • Shah PD; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University Medical Center, Baltimore, Maryland.
  • Orens JB; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University Medical Center, Baltimore, Maryland.
  • Dhillon GS; Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Palo Alto, California.
  • Lama VN; Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center, Ann Arbor, Michigan.
  • Patel MG; Division of Pulmonary and Critical Care Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
  • Singer JP; Division of Pulmonary and Critical Care Allergy and Sleep Medicine, University of California, San Francisco, San Francisco, California.
  • Hachem RR; Division of Pulmonary and Critical Care Medicine, Washington University, St. Louis, Missouri.
  • Michelson AP; Division of Pulmonary and Critical Care Medicine, Washington University, St. Louis, Missouri.
  • Hsu J; Division of Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Russell Localio A; Division of Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Christie JD; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
J Heart Lung Transplant ; 43(4): 633-641, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38065239
BACKGROUND: Primary graft dysfunction (PGD) is the leading cause of early morbidity and mortality after lung transplantation. Accurate prediction of PGD risk could inform donor approaches and perioperative care planning. We sought to develop a clinically useful, generalizable PGD prediction model to aid in transplant decision-making. METHODS: We derived a predictive model in a prospective cohort study of subjects from 2012 to 2018, followed by a single-center external validation. We used regularized (lasso) logistic regression to evaluate the predictive ability of clinically available PGD predictors and developed a user interface for clinical application. Using decision curve analysis, we quantified the net benefit of the model across a range of PGD risk thresholds and assessed model calibration and discrimination. RESULTS: The PGD predictive model included distance from donor hospital to recipient transplant center, recipient age, predicted total lung capacity, lung allocation score (LAS), body mass index, pulmonary artery mean pressure, sex, and indication for transplant; donor age, sex, mechanism of death, and donor smoking status; and interaction terms for LAS and donor distance. The interface allows for real-time assessment of PGD risk for any donor/recipient combination. The model offers decision-making net benefit in the PGD risk range of 10% to 75% in the derivation centers and 2% to 10% in the validation cohort, a range incorporating the incidence in that cohort. CONCLUSION: We developed a clinically useful PGD predictive algorithm across a range of PGD risk thresholds to support transplant decision-making, posttransplant care, and enrich samples for PGD treatment trials.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Pulmón / Disfunción Primaria del Injerto Límite: Humans Idioma: En Revista: J Heart Lung Transplant Asunto de la revista: CARDIOLOGIA / TRANSPLANTE Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Pulmón / Disfunción Primaria del Injerto Límite: Humans Idioma: En Revista: J Heart Lung Transplant Asunto de la revista: CARDIOLOGIA / TRANSPLANTE Año: 2024 Tipo del documento: Article